Drug Trial Radar · NCT05623540
Bisphosphonates Use After Total Joint Arthroplasty
Last checked: Nov 19, 2026Latest source record: Nov 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
27,405
Actual
Start
Jan 1, 2000
Primary completion
Dec 31, 2015
Study completion Nov 2, 2022
Sponsor
- Lead sponsor
- National Defense Medical Center, TaiwanAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 21, 2022
Design
- Study type
- Observational
- FDA-regulated drug
- No
- Who can join
- All sexes, from 40 years
Summary
As written by the sponsor on the registry.
Background Bisphosphonates has been associated with a decreased risk of revision total joint replacements because of its effects on decreased periprosthetic bone loss and prosthetic migration. However, the results in the early literature are inconsistent and the influence of bisphosphonates on associated complications and subsequent total joint arthroplasty (TJA) remains unknown. This study is to investigate the association between the use of bisphosphonates and risk of adverse outcomes after primary TJA. Materials and Methods This matched cohort study utilized National Health Insurance Research Database in Taiwan to identify patients who underwent primary TJA over a 15-year period (January 2000- December 2015 inclusive). Study participants were further categorized into two groups: bisphosphonates users and nonusers, using propensity score matching. The Kaplan-Meier curve analysis and adjusted hazard ratios (aHR) of revision surgery, adverse outcomes of primary surgery and undergoing subsequent TJA were calculated using Cox regression analysis.
Conditions
- Diphosphonates
Interventions
Bisphosphonates, CombinationsDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- revision rate of joint arthroplastyTime frame: a 15-year period (January 2000- December 2015 inclusive)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tri-Service General Hospital, National Defense Medical Center
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.